🕵️ Hepion Pharmaceuticals, Inc. ($HEPA)
SEC insider & ownership activity, last 12 months · CIK 1583771 · every row links its SEC filing
Over the last 12 months insiders bought $400K with no open-market selling against it. Vincent S. Lopriore bought $250K in discretionary trades (Apr). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
4 buyers, $400K (5 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Vincent S. Lopriore | 2 | $250K | 0 | – | Apr 21, 2026 |
| Michael J. Purcell | 1 | $50K | 0 | – | Apr 21, 2026 |
| Gary S. Stetz | 1 | $50K | 0 | – | Apr 21, 2026 |
| Appajosyula Sireesh | 1 | $50K | 0 | – | Apr 21, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Vincent Lopriore | 21.5% | 13D | Apr 21, 2026 | filing ↗ | |
| Gravitas Capital LP | 17.2% | 13D | Apr 21, 2026 | filing ↗ | |
| Bigger Capital Fund L P | 10.0% | 13G | Jan 24, 2025 | filing ↗ | |
| Bigger Capital Fund GP, LLC | 10.0% | 13G | Jan 24, 2025 | filing ↗ | |
| Bigger Michael | 10.0% | 13G | Jan 24, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 1, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 21, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 21, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 16, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 25, 2026 | filing ↗ |
| Other events (8.01) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 3, 2026 | filing ↗ |